Hayashi Nobuhiko

ハヤシノブヒコ | Hayashi Nobuhiko

Affiliation and department：
Papers (29)：

Ryuichi Kubota, Nobuhiko Hayashi, Kaori Kinoshita, Takashi Saito, Kazuaki Ozaki, Yoshimichi Ueda, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Joseph George. Inhibition of γ-glutamyltransferase ameliorates ischemia-reoxygenation tissue damage in rats with hepatic steatosis. British Journal of Pharmacology. 2020. 177. 22. 5195-5207
Yuki Hirakawa, Mutsumi Tsuchishima, Atsushi Fukumura, Kaori Kinoshita, Nobuhiko Hayashi, Takashi Saito, Joseph George, Toshikuni Nobuyuki, Ueda Yoshimichi, Tsutsumi Mikihiro. Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats. European Journal of Pharmacology. 2019. 863. 172681
Kaori Kinoshita, Nobuyuki Toshikuni, Takashi Saito, Nobuhiko Hayashi, Takahiro Minato, Yasuhiro Matsue, Yoshimichi Ueda, Mutsumi Tsuchishima, Mikihiro Tsutsumi. The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people. Turkish Journal ofMedical Scences. 2019. 49. 1350-1357
Nobuyuki Toshikuni, Yasuhiro Matsue, Kazuaki Ozaki, Kaho Yamada, Nobuhiko Hayashi, Mutsumi Tsuchishima, Mikihiro Tsutsumi. An image fusion system for estimating the therapeutic effects of radiofrequency ablation on hepatocellular carcinoma. RADIOLOGY AND ONCOLOGY. 2017. 51. 3. 263-269
Kaneto Tamura, Nobuhiko Hayashi, Joseph George, Nobuyuki Toshikuni, Tomiyasu Arisawa, Jun Hiratake, Mutsumi Tsuchishima, Mikihiro Tsutsumi. GGsTop, a novel and specific gamma-glutamyl transpeptidase inhibitor, protects hepatic ischemia-reperfusion injury in rats. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY. 2016. 311. 2. G305-G312

ｍore...

Books (2)：

アルコール性肝障害の病態
2014
8 アルコール性肝障害
2013

Lectures and oral presentations (133)：

血清%CDT(糖査欠損トランスフェリン)値がcut off値以下のアルコール性肝障害患者の特徴
(第24回日本肝臓学会大会 2020)
Inhibition of g-glutamyl transpeptidase ameliorates hepatic ischemia/reperfusion injury in rats with fatty liiver.
(The Digital International Liver Congress (EASL-ILC 2020) 2020)
Serum miRNA-320 as a potent diagnostic biomarker for human hepatocellular carcinoma irrespective of etiology
(The 29th Annual Convention of the Asian Pacific Association for the Study of the Liver 2020)
アルコール性脂肪肝炎および非アルコール性脂肪肝炎と高血圧症、2型糖尿病、脂質異常症との関連性
(第39回アルコール医学生物学研究会学術集会 2020)
肝硬変を合併したプロリダーゼ欠損症の1例
(第43回日本肝臓学会西部会 2019)

ｍore...

Education (2)：

2002 - 2006 Kanazawa Medical University Graduate School
1996 - 2002 Kanazawa Medical University

Professional career (1)：

Doctor of medicine

Work history (1)：

2007/04 - Kanazawa medical university

Awards (4)：

2014 - Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.PloS one. 8(7):e70034
2013 - Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.PLoS ONE,8:e70034
2013 - 金沢医科大学橘勝会金沢医科大学「橘会賞」 Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.PLoS ONE,8:e70034
2013 - 金沢医科大学橘勝会金沢医科大学「橘会賞」 Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease.PLoS ONE,8:e70034

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page